Placentitis

Placentitis in mares refers to inflammation and infection of the placenta, the critical structure providing oxygen and nutrients to the developing fetus while removing waste products throughout pregnancy. This serious condition threatens pregnancy viability by disrupting placental function, potentially causing abortion, stillbirth, premature delivery, or birth of compromised foals. Understanding placentitis is essential for broodmare managers and equine veterinarians, as early recognition and aggressive treatment offer the best chances of saving affected pregnancies and producing healthy foals.

Placentitis affects mares of all breeds and can occur at any stage of pregnancy, though it most commonly becomes clinically apparent during the last trimester when placental demands peak and monitoring intensifies. The condition occurs in several distinct forms based on the route of infection and location of placental damage. Ascending placentitis, the most common form, results from organisms entering through the cervix and attacking the placenta from the cervical star outward. Less common forms include nocardioform placentitis affecting the base of the pregnant horn and hematogenous placentitis resulting from bloodborne spread of infection to the placenta.

The impact of placentitis on pregnancy outcomes ranges from complete pregnancy loss to delivery of healthy foals depending on severity, timing of detection, and treatment response. Untreated or severe placentitis typically results in abortion or delivery of non-viable premature foals. Even with treatment, significant placental compromise may produce foals that are premature, dysmature, or suffer from neonatal conditions requiring intensive care. The economic impact extends beyond the lost pregnancy itself to include treatment costs, potential foal hospitalization expenses, and effects on future breeding plans. Emotional toll on owners invested in specific pregnancies adds to the condition's significance.

Fortunately, placentitis is treatable when detected early, with modern therapeutic protocols significantly improving outcomes compared to historical expectations. Ultrasonographic monitoring of placental thickness and characteristics allows identification of developing problems before clinical signs become apparent. Aggressive multimodal therapy combining antimicrobials, anti-inflammatories, and progestins supports pregnancy continuation while combating infection. Many mares with promptly diagnosed and treated placentitis successfully deliver healthy foals, though vigilant monitoring and willingness to maintain long-term treatment are essential for success.

The primary causes of placentitis involve bacterial, fungal, or occasionally viral organisms gaining access to the placental membranes and inciting inflammation. Ascending placentitis results from organisms entering through the vagina and cervix, with common bacterial isolates including Streptococcus equi subspecies zooepidemicus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Fungal organisms including Aspergillus species and various yeasts also cause ascending infections. The cervix normally provides a tight seal protecting the pregnancy, but any compromise of this barrier allows pathogen entry. Nocardioform placentitis is caused by Crossiella equi and related organisms, attacking the placenta at a characteristic location near the base of the pregnant horn.

Genetic factors do not directly cause placentitis, though inherited conformational characteristics significantly influence susceptibility. Mares inheriting poor vulvar conformation that allows fecal contamination of the vestibule face increased ascending infection risk. Cervical competence, partially determined by anatomical factors that may have heritable components, affects the cervix's ability to maintain pregnancy protection. These conformational susceptibilities can appear repeatedly within family lines, though the actual infection represents an acquired condition rather than an inherited disease.

Environmental and management factors substantially influence placentitis development. Pasture contamination with causative organisms increases exposure risk, particularly for nocardioform placentitis where environmental sources predominate. Unsanitary housing conditions elevate bacterial load near vulnerable mares. Geographic location affects organism prevalence, with nocardioform placentitis concentrated in specific regions including parts of Kentucky and Florida. Breeding practices that compromise cervical integrity or introduce organisms to the reproductive tract may predispose to later ascending infection during pregnancy. Stress from transportation, weather extremes, or management changes may reduce immune defenses against developing infection.

Risk factors for placentitis encompass mare characteristics, management practices, and pregnancy history. Poor vulvar conformation allowing pneumovagina creates a constant contamination source potentially overwhelming cervical defenses. Cervical incompetence from age-related changes, previous injury, or repeat pregnancies reduces barrier function. History of previous placentitis indicates ongoing susceptibility warranting enhanced monitoring. Older mares demonstrate increased susceptibility compared to younger counterparts. Twin pregnancy, though uncommon to continue to late gestation, increases placental stress and infection risk.

The pathophysiology of placentitis involves progressive placental damage from infectious and inflammatory processes. In ascending placentitis, organisms establish themselves at the cervical star, the site of placental attachment over the internal cervical os, then spread outward across the placental surface. Inflammation causes placental thickening, separation from the uterine wall, and functional compromise of nutrient and oxygen exchange. The fetus responds to placental insufficiency with stress responses including accelerated maturation of some organ systems. Untreated progression leads to increasing placental separation, premature placental detachment, and pregnancy loss through abortion, stillbirth, or premature delivery of a compromised foal unable to survive.

Early warning signs of placentitis are often subtle and may be detected only through careful monitoring rather than obvious clinical observation. Ultrasonographic changes in placental thickness and appearance typically precede clinical signs by days to weeks, making regular monitoring essential for at-risk mares. Mild vulvar discharge may appear before other signs develop, though this finding is easily overlooked or attributed to normal pregnancy secretions. Increased fetal activity detected by the mare owner or during ultrasound examination sometimes indicates fetal stress from placental compromise. These early signs provide crucial windows for intervention when treatment has the greatest chance of success.

Common symptoms of established placentitis include vulvar discharge that may range from clear to mucopurulent depending on the causative organisms and infection severity. This discharge represents leakage of infected material past the cervix and may be visible on the vulva, tail, or inner thighs. Premature mammary development, with udder enlargement and milk production occurring weeks before the expected foaling date, strongly suggests placental problems triggering early lactation. Premature vulvar relaxation and cervical softening indicate hormonal changes associated with impending delivery before term.

Behavioral changes in mares with placentitis may be minimal or significant depending on individual variation and disease severity. Some mares show mild restlessness or discomfort, while others appear completely normal despite significant placental pathology. Changes in appetite sometimes accompany advancing disease. Increased frequency of urination posturing may occur. Social behavior alterations including withdrawal from herd mates or reduced activity level develop in some affected mares. The unreliability of behavioral indicators emphasizes the importance of objective monitoring methods for placentitis detection.

Physical signs detectable on examination center on vulvar discharge and reproductive tract changes. Speculum examination may reveal discharge pooled in the cranial vagina. Cervical examination shows softening and relaxation in advanced cases. Transrectal ultrasound examination, the primary diagnostic tool, reveals characteristic placental thickening at the cervical star in ascending placentitis, with normal thickness being less than approximately eight millimeters at the cervical pole during late gestation. Placental separation appears as hypoechoic areas between the placenta and uterine wall. Fetal assessment evaluates viability, activity, and signs of stress.

Symptom progression in untreated placentitis follows predictable but variable timelines toward pregnancy loss. Placental changes identified ultrasonographically worsen, with increasing thickness and expanding areas of compromise. Discharge volume typically increases as infection progresses. Premature lactation advances with milk becoming more mature in composition. Cervical changes accelerate toward delivery readiness despite inadequate gestational age. Eventually, progression reaches a point where pregnancy loss becomes inevitable despite intervention, whether through abortion of a non-viable fetus, stillbirth, or delivery of a premature foal unable to survive.

Emergency symptoms requiring immediate veterinary care include heavy vulvar discharge particularly if purulent or foul-smelling, active premature labor with contractions and bearing down efforts before term, ruptured membranes before gestational maturity, or delivery of a premature foal requiring immediate neonatal support. Any late-pregnant mare showing vulvar discharge warrants urgent evaluation to assess pregnancy viability and treatment options. Active abortion in progress requires veterinary attendance for mare monitoring, assistance if needed, and tissue collection for diagnostic submission.

Physical examination for suspected placentitis begins with external assessment before proceeding to reproductive tract evaluation. General mare health status including vital signs, attitude, and body condition are noted. External observation of the udder assesses for premature development including enlargement, edema, and milk production. The vulva is inspected for discharge and relaxation inappropriate for gestational age. Tail and hindquarter examination reveals discharge accumulation that might have been missed on casual observation. This initial assessment guides the urgency and extent of subsequent diagnostic procedures.

Diagnostic testing for placentitis relies heavily on ultrasonographic evaluation of placental and fetal status. Transrectal ultrasound examination measures combined thickness of the uterus and placenta (CTUP) at standardized locations, comparing values to established normal ranges for gestational age. The cervical star region receives particular attention in ascending placentitis, where thickening typically first appears. Placental separation appears as anechoic fluid accumulation between placenta and uterine wall. Fetal assessment includes heart rate measurement, activity level evaluation, and amniotic fluid character examination. Transabdominal ultrasound provides additional fetal visualization and allows assessment of placental areas beyond transrectal reach.

Advanced diagnostic procedures supplement ultrasonographic findings in selected cases. Amniocentesis, sampling of amniotic fluid, provides direct assessment for infection through culture and cytology, though the procedure carries risks including pregnancy disruption and is not routinely performed. Hormone analysis may support diagnosis, with inappropriately low progestin levels suggesting placental compromise. When abortion occurs or premature foals are delivered, culture of placental tissues identifies causative organisms and guides antimicrobial selection for any subsequent treatment. Histopathological examination of placentas from affected pregnancies characterizes the nature and extent of damage.

Differential diagnosis for placentitis includes other causes of vulvar discharge and premature delivery. Normal cervical mucus production during late pregnancy may cause mild discharge without pathologic significance. Vaginal or cervical trauma unrelated to placentitis can produce discharge requiring differentiation. Other causes of abortion or premature delivery including equine herpesvirus, leptospirosis, and mare reproductive loss syndrome share some presentations with placentitis. Premature placental separation without infection may cause similar problems. Accurate diagnosis ensures appropriate treatment selection and realistic prognosis communication.

Emergency treatment for acute placentitis presentations focuses on rapid initiation of pregnancy-supporting therapy. Broad-spectrum antimicrobial therapy begins immediately based on likely causative organisms, with trimethoprim-sulfamethoxazole combinations commonly selected for initial treatment pending culture results. Progestin supplementation using altrenogest supports pregnancy continuation by maintaining hormonal conditions opposing uterine contractility. Anti-inflammatory therapy with non-steroidal medications reduces inflammation contributing to placental damage and early labor stimulation. Pentoxifylline may be added for its rheological effects supporting placental circulation. This aggressive initial approach aims to halt disease progression while more definitive diagnostic information is gathered.

Medical management of placentitis continues for extended periods, often months, requiring owner commitment and veterinary monitoring. Antimicrobial selection is refined based on culture results when available, with treatment continuing until delivery regardless of apparent improvement. Altrenogest administration continues throughout the treatment period, typically until delivery timing approaches when natural hormonal changes must be allowed to progress. Anti-inflammatory therapy is maintained or periodically administered throughout pregnancy. Tocolytic agents that relax uterine muscle, such as clenbuterol, may be added if uterine contractions are detected. Treatment protocols are individualized based on case severity, gestational age, and treatment response.

Surgical interventions for placentitis are extremely limited, as the condition affects internal structures not amenable to direct surgical correction. However, Caslick's procedure to improve vulvar seal may be performed in mares with conformational defects contributing to ascending infection, providing additional protection against ongoing contamination. Cervical abnormalities identified during evaluation might warrant future surgical attention, though not during the affected pregnancy. The fundamental treatment approach remains medical rather than surgical.

Supportive care measures complement antimicrobial and hormonal therapy. Nutritional support maintains mare body condition and provides substrates for fetal growth despite placental compromise. Stress minimization through appropriate housing, handling, and management reduces factors that could trigger premature delivery. Monitoring for signs of impending labor allows preparation for potential premature delivery requiring neonatal support. Plans for foal care should include arrangements for neonatal intensive care capability if premature delivery occurs. Mare comfort through appropriate bedding, temperature management, and routine care supports overall wellbeing.

Preparation for delivery and neonatal care represents a critical component of placentitis case management. Treatment goals include extending pregnancy as long as safely possible to maximize fetal maturity, but delivery will eventually occur and may happen prematurely despite treatment. Identifying the nearest facility capable of neonatal intensive care allows rapid transport if needed. Stockpiling colostrum or plasma provides backup for potentially compromised passive transfer. Having experienced personnel available for delivery assistance and immediate foal assessment optimizes outcomes for premature or compromised foals. These preparations hope for the best while planning for potential complications.

Treatment decision factors include gestational age, disease severity, treatment response, and practical considerations. Earlier gestational age at diagnosis generally carries poorer prognosis regardless of treatment intensity. Severe placental compromise visible ultrasonographically may indicate pregnancy loss likelihood despite aggressive therapy. Response to initial treatment within the first weeks guides decisions about continued management intensity. Mare value and owner investment influence willingness to pursue prolonged, expensive treatment courses. Realistic discussion of likely outcomes helps owners make informed decisions about treatment intensity and duration.

Recovery timeline for placentitis extends throughout the remainder of pregnancy and into the post-foaling period. During pregnancy, treatment continues with monitoring for improvement or deterioration. Ultrasonographic improvement including decreased placental thickness and resolution of separation provides encouraging signs, though complete normalization is uncommon. The goal shifts from cure to pregnancy maintenance long enough for fetal viability. Post-delivery assessment of mare recovery from pregnancy and any concurrent conditions completes the recovery process. The true recovery endpoint is successful delivery of a viable foal.

Post-treatment care and monitoring during ongoing pregnancy require regular veterinary assessment. Ultrasonographic examinations every one to four weeks track placental status and fetal development. Fetal monitoring including heart rate assessment provides viability confirmation. Mammary development tracking indicates progression toward delivery. Hormonal support continues with regular altrenogest administration. Any worsening of ultrasonographic findings or development of new clinical signs prompts reassessment and potential treatment modification. This vigilant monitoring continues until delivery occurs.

Prognosis factors for placentitis outcomes include gestational age at diagnosis, severity of placental changes, causative organism, and treatment response. Mares diagnosed earlier in the disease process before extensive placental damage develops have better outcomes than those with advanced changes at presentation. Gestational age matters significantly, with foals delivered before approximately three hundred twenty days gestation facing substantially higher mortality and morbidity. Bacterial placentitis generally carries better prognosis than fungal infections. Early response to treatment with ultrasonographic improvement suggests favorable outcome potential.

Long-term fertility outlook for mares following placentitis depends on underlying causes and any permanent reproductive tract changes. Mares with conformational defects predisposing to ascending infection face ongoing susceptibility requiring enhanced management during future pregnancies. Cervical damage from infection or delivery complications may affect future pregnancy security. Many mares successfully conceive and carry subsequent pregnancies normally when predisposing factors are addressed. Endometrial biopsy may help assess uterine health and predict future fertility. Previous placentitis history warrants enhanced monitoring during subsequent pregnancies to detect any recurrence early.

Management practices for placentitis prevention focus on protecting the pregnant uterus from infectious challenge. Maintaining excellent vulvar seal through Caslick's procedure in mares with poor conformation prevents ascending contamination throughout pregnancy. The procedure is typically performed after breeding confirmation and opened only near foaling. Routine reproductive hygiene during breeding minimizes introduction of organisms that might later cause problems. Separating pregnant mares from potential infection sources including sick horses or heavily contaminated environments reduces exposure risk.

Nutritional prevention supports optimal immune function and pregnancy health. Balanced diets meeting all requirements for pregnant mares maintain disease resistance. Adequate vitamin E and selenium support immune function without excessive supplementation. Body condition maintenance between five and seven during pregnancy provides reserves for immune function while avoiding obesity-related complications. Appropriate mineral supplementation based on regional deficiencies and individual needs supports overall health contributing to disease resistance.

Exercise and conditioning considerations during pregnancy balance mare fitness maintenance against avoiding excessive stress. Regular moderate exercise supports cardiovascular health beneficial for pregnancy maintenance. Avoiding strenuous exertion that could stress the pregnancy seems prudent though specific connections to placentitis risk remain unestablished. Turnout allowing natural movement patterns contributes to mare wellbeing. Activity levels should be appropriate to individual mare fitness and pregnancy stage without extreme approaches in either direction.

Environmental factors substantially influence placentitis exposure risk. Clean pastures with appropriate stocking density reduce pathogen accumulation in mare environments. Fescue-free pastures eliminate endophyte exposure that can cause other pregnancy complications. Regional consideration of nocardioform placentitis endemic areas may influence farm location decisions or management intensity for mares in affected regions. Well-maintained facilities with appropriate hygiene reduce bacterial load in mare environments.

Monitoring protocols represent the most practical approach to placentitis prevention through early detection. Regular ultrasonographic examination of pregnant mares, particularly during the last trimester, identifies developing problems when intervention is most effective. At-risk mares including those with previous placentitis, conformational defects, or advanced age warrant more intensive monitoring schedules. Owner education about clinical signs prompts early veterinary consultation when problems develop. This surveillance approach catches placentitis early when treatment success rates are highest.

Daily management adjustments for mares under treatment for placentitis balance pregnancy support against practical feasibility. Housing should minimize stress while providing appropriate conditions for monitoring. Clean, well-bedded stalls allow observation of discharge, behavior changes, and signs of labor. Feeding schedules and diet composition support pregnancy nutrition without excessive management disruption. Medication administration according to veterinary protocols requires owner commitment to consistent treatment schedules. Daily observation for clinical changes allows early recognition of improvement or deterioration.

Housing and turnout considerations during placentitis treatment weigh activity benefits against monitoring needs and delivery preparedness. Stall rest was traditionally recommended but may not benefit outcomes compared to small paddock turnout for stable mares. Confined housing facilitates medication administration and monitoring. Mares should not be housed far from observation where developing labor might go unnoticed. Climate control may benefit mares in extreme weather conditions. Foaling stall readiness allows rapid response if delivery begins.

Exercise modifications during placentitis treatment generally favor rest or limited activity. Stall rest with hand walking may be appropriate for mares showing signs of impending labor or with severe placental compromise. Stable mares without active labor signs may tolerate small paddock turnout under close observation. Strenuous exercise should be avoided as pregnancy progresses and risk of triggering premature delivery increases. Individual case characteristics guide activity recommendations with veterinary guidance.

Monitoring and ongoing care requirements for placentitis cases extend throughout treatment and into the post-delivery period. Twice daily observation notes appetite, attitude, mammary development, and vulvar discharge. Temperature monitoring may detect developing sepsis. Serial veterinary examinations track treatment response and guide management adjustments. Preparation for possible premature delivery includes identifying neonatal care resources. Post-foaling care addresses mare recovery and any foal health concerns resulting from the compromised pregnancy.

Quality of life and use considerations during placentitis treatment prioritize pregnancy preservation over other mare activities. Riding or other performance use typically ceases during treatment to minimize pregnancy stress. Social needs may be met through adjacent housing allowing visual and fence line contact without group turnout risks. Mental stimulation through varied feeding and environmental enrichment helps maintain mare welfare during restricted management. The temporary nature of these restrictions, lasting only through the remainder of pregnancy, makes intensive management feasible for most owners.

Placentitis affects mares of all breeds without clear breed-specific susceptibility, with individual and management factors more predictive than breed identity. However, conformational characteristics predisposing to ascending infection appear more frequently in some breeds. Thoroughbreds may demonstrate poor vulvar conformation at higher rates than some other breeds, though individual variation exceeds breed differences. Arabian and other refined breeds with fine tissue quality may show higher rates of cervical incompetence contributing to ascending infection susceptibility. Draft breeds' generally robust conformation may provide relative protection against ascending placentitis, though all breeds remain susceptible.

Use and discipline affect placentitis risk through associated management practices and mare populations. Intensively managed breeding operations may identify more placentitis cases through enhanced monitoring compared to less supervised populations. Racing industry mares bred at older ages after athletic careers may face increased susceptibility from age-related reproductive changes. Regional concentration of breeding operations in areas endemic for nocardioform placentitis creates apparent breed associations actually reflecting geographic management. Sport horse and warmblood breeding programs face similar placentitis risks as other segments despite different selection criteria.

Genetic testing and breeding recommendations for placentitis prevention focus on conformational selection rather than specific genetic markers. Avoiding breeding mares with severe vulvar conformation defects to stallions that might perpetuate these characteristics reduces predisposition in future generations. Selection for reproductive soundness and efficiency supports overall population health. Documentation of placentitis occurrences within breeding programs may reveal patterns suggesting susceptibility worth addressing through breeding decisions. Current understanding supports general reproductive health selection rather than placentitis-specific genetic management.

Commonly co-occurring conditions with placentitis include other reproductive tract infections that may share causative organisms or predisposing factors. Endometritis may precede pregnancy or develop concurrently with placental infection. Cervicitis compromises the cervical barrier protecting pregnancy. Pneumovagina from poor vulvar conformation contributes contamination predisposing to ascending infection. Post-partum metritis may follow delivery of placentitis-affected pregnancies, particularly when placental retention occurs. These conditions often share underlying anatomical predispositions and management of one addresses risk for others.

Conditions presenting with similar clinical signs to placentitis require differentiation for appropriate management. Normal late pregnancy changes including cervical relaxation and early mammary development may mimic placentitis signs in mares approaching term. Other causes of abortion including equine herpesvirus infection, mare reproductive loss syndrome, and twin pregnancy complications share some presentations. Premature placental separation without infection causes similar problems but may warrant different management. Fescue toxicosis causes prolonged pregnancy and mammary dysfunction through different mechanisms. Accurate diagnosis through ultrasonographic evaluation distinguishes placentitis from these alternatives.

Potential complications of placentitis extend from pregnancy loss through neonatal morbidity in surviving foals. Abortion represents complete pregnancy loss when placentitis progresses beyond treatment capacity. Premature delivery produces foals of varying viability depending on gestational age and in utero compromise. Premature foals face respiratory distress, failure of passive transfer, sepsis risk, and numerous other complications requiring intensive care. Dysmature foals may appear full term but show inappropriate organ maturation affecting survival. Post-delivery complications in mares include retained placenta, metritis, and laminitis, particularly following complicated deliveries. Long-term consequences may include reduced fertility from reproductive tract damage.